Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
143 hedge funds and large institutions have $770M invested in Momenta Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 66 increasing their positions, 30 reducing their positions, and 24 closing their positions.
427% more call options, than puts
Call options by funds: $5.99M | Put options by funds: $1.14M
120% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 30
38% more capital invested
Capital invested by funds: $558M → $770M (+$212M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
3% less funds holding
Funds holding: 148 → 143 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23.8M |
| 3 |
VAM
Visium Asset Management
New York
|
+$7.79M |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$4.6M |
| 5 |
JP Morgan Chase
New York
|
+$4.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$30.1M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$14.6M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$9.28M |
| 4 |
Citigroup
New York
|
-$5M |
| 5 |
Morgan Stanley
New York
|
-$4.82M |
MNTA Hedge Fund Activity: Q1 2015 in Review
143 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q1 2015, worth a combined $770M — up 38% from $558M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of MNTA and 22 opened new positions — a net loss of 2 holders — while 30 trimmed existing stakes and 66 added.
The largest buyer was Fidelity Investments, adding an estimated $48.4M. The largest seller was North Tide Capital, exiting entirely with an estimated $30.1M sold.
- 143 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q1 2015, down from 148 in Q4 2014.
- Funds reported $770M of Momenta Pharmaceuticals, Inc. stock for Q1 2015, up 38% quarter-over-quarter.
- 22 funds opened new Momenta Pharmaceuticals, Inc. positions in Q1 2015 and 24 closed out, a net change of -2 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q1 2015 was Fidelity Investments, an estimated $48.4M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q1 2015 was North Tide Capital, an estimated $30.1M sold.
Based on aggregated 13F filings for Q1 2015.